Resero Bio, RARE-seq, uRARE-seq, Cell-Free RNA, cfRNA, Liquid Biopsy, Bladder Cancer, Urothelial Cancer, Nature Medicine, Precision Oncology, Molecular Residual Disease, MRD, BCG Immunotherapy

San Carlos, California, U.S., October 5, 2026 Resero Bio has announced publication of a Stanford-led study in Nature Medicine...